Search

everythinglearnresearchcommunity

for

Search:↓

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

KX-826 is safe and effectively increases hair count in men with hair loss.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Erlotinib can cause hair loss and texture changes.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

RTA 408 cream protects mice from radiation skin damage.

Transplanting a person's own hair can heal chronic wounds in certain skin conditions.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Baricitinib may effectively treat oral lichen planus.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

The treatment was ineffective in humans.